Company registration number 05437516 (England and Wales)
Boulton Dental Laboratories Limited
UNAUDITED FINANCIAL STATEMENTS
for the year ended 30 April 2025
PAGES FOR FILING WITH REGISTRAR
Boulton Dental Laboratories Limited
Contents
Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 5
Boulton Dental Laboratories Limited
Statement of financial position
as at 30 April 2025
30 April 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
3,000
6,000
Tangible assets
4
143,861
118,213
Investment property
5
199,735
199,735
346,596
323,948
Current assets
Stocks
3,985
3,529
Debtors
42,964
44,050
Cash at bank and in hand
239,078
225,053
286,027
272,632
Creditors: amounts falling due within one year
(47,396)
(48,710)
Net current assets
238,631
223,922
Total assets less current liabilities
585,227
547,870
Creditors: amounts falling due after more than one year
(3,028)
(11,613)
Provisions for liabilities
(6,940)
(1,797)
Net assets
575,259
534,460
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
575,159
534,360
Total equity
575,259
534,460
Boulton Dental Laboratories Limited
Statement of financial position (continued)
as at 30 April 2025
30 April 2025
- 2 -

For the financial year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with section 444 of the Companies Act 2006, all of the members of the company have consented to the preparation of abridged financial statements pursuant to paragraph 1A of Schedule 1 to the Small Companies and Groups (Accounts and Directors’ Report) Regulations (SI 2008/409)(b).

The director of the company has elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 6 January 2026
P R Boulton
Director
Company registration number 05437516 (England and Wales)
Boulton Dental Laboratories Limited
Notes to the financial statements
for the year ended 30 April 2025
- 3 -
1
Accounting policies
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

Turnover

Turnover represents the total invoice value of sales made during the year. Turnover is recognised upon provision of services to customers.

Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost less depreciation.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
No depreciation
Plant and machinery
15% on written down value
Computer equipment
15% on written down value
Motor vehicles
25% on written down value
Investment property

Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.

Stocks

Stock is valued at the lower of the cost and net realisable value.

Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Boulton Dental Laboratories Limited
Notes to the financial statements (continued)
for the year ended 30 April 2025
1
Accounting policies
(continued)
- 4 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
9
9
3
Intangible fixed assets
Goodwill
£
Cost
At 1 May 2024 and 30 April 2025
30,000
Amortisation and impairment
At 1 May 2024
24,000
Amortisation charged for the year
3,000
At 30 April 2025
27,000
Carrying amount
At 30 April 2025
3,000
At 30 April 2024
6,000
Boulton Dental Laboratories Limited
Notes to the financial statements (continued)
for the year ended 30 April 2025
- 5 -
4
Tangible fixed assets
Freehold land and buildings
Plant and machinery
Computer equipment
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 May 2024
111,025
321
350
7,188
118,884
Additions
-
0
-
0
-
0
32,228
32,228
At 30 April 2025
111,025
321
350
39,416
151,112
Depreciation and impairment
At 1 May 2024
-
0
321
350
-
0
671
Depreciation charged in the year
-
0
-
0
-
0
6,580
6,580
At 30 April 2025
-
0
321
350
6,580
7,251
Carrying amount
At 30 April 2025
111,025
-
0
-
0
32,836
143,861
At 30 April 2024
111,025
-
0
-
0
7,188
118,213
5
Investment property
2025
£
Fair value
At 1 May 2024 and 30 April 2025
199,735
6
Company information

Boulton Dental Laboratories Limited is a private company limited by shares incorporated in England and Wales. The registered office is West House, King Cross Road, Halifax, West Yorkshire, HX1 1EB.

2025-04-302024-05-01falsefalsefalse06 January 2026CCH SoftwareCCH Accounts Production 2025.300No description of principal activityP R Boulton054375162024-05-012025-04-30054375162025-04-30054375162024-04-3005437516core:Goodwill2025-04-3005437516core:Goodwill2024-04-3005437516core:LandBuildingscore:OwnedOrFreeholdAssets2025-04-3005437516core:PlantMachinery2025-04-3005437516core:ComputerEquipment2025-04-3005437516core:MotorVehicles2025-04-3005437516core:LandBuildingscore:OwnedOrFreeholdAssets2024-04-3005437516core:PlantMachinery2024-04-3005437516core:ComputerEquipment2024-04-3005437516core:MotorVehicles2024-04-3005437516core:CurrentFinancialInstruments2025-04-3005437516core:CurrentFinancialInstruments2024-04-3005437516core:Non-currentFinancialInstruments2025-04-3005437516core:Non-currentFinancialInstruments2024-04-3005437516core:ShareCapital2025-04-3005437516core:ShareCapital2024-04-3005437516core:RetainedEarningsAccumulatedLosses2025-04-3005437516core:RetainedEarningsAccumulatedLosses2024-04-3005437516bus:Director12024-05-012025-04-3005437516core:Goodwill2024-05-012025-04-3005437516core:LandBuildingscore:OwnedOrFreeholdAssets2024-05-012025-04-3005437516core:PlantMachinery2024-05-012025-04-3005437516core:ComputerEquipment2024-05-012025-04-3005437516core:MotorVehicles2024-05-012025-04-30054375162023-05-012024-04-3005437516core:Goodwill2024-04-3005437516core:LandBuildingscore:OwnedOrFreeholdAssets2024-04-3005437516core:PlantMachinery2024-04-3005437516core:ComputerEquipment2024-04-3005437516core:MotorVehicles2024-04-30054375162024-04-3005437516bus:PrivateLimitedCompanyLtd2024-05-012025-04-3005437516bus:SmallCompaniesRegimeForAccounts2024-05-012025-04-3005437516bus:FRS1022024-05-012025-04-3005437516bus:AuditExemptWithAccountantsReport2024-05-012025-04-3005437516bus:FullAccounts2024-05-012025-04-30xbrli:purexbrli:sharesiso4217:GBP